Select Page

It's packed with all of the company's key stats and salient decision making information. Business Wire . Zacks Rank Education -- Learn more about the Zacks Rank Here is a synopsis of all five stocks: Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Reblog. These revisions help to show the ever-changing nature of near-term business trends. The Medical - Biomedical and Genetics industry is part of the Medical sector. Visit www.zacksdata.com to get our data and content for your mobile app or website. Today, you can download 7 Best Stocks for the Next 30 Days. PFE: 36.81 (+0.19%) MRK: 81.80 (+1.50%) BMY: 62.03 (+0.18%) CORT: 26.16 (-0.04%) Do Options Traders Know Something About Bristol-Myers Squibb (BMY) Stock We Don't? Meanwhile, our latest consensus estimate is calling for revenue of $10.57 billion, up 32.98% from the prior-year quarter. Bristol-Myers Squibb Company (BMY) Stock Price: $61.38 USD-0.65 (-1.05%) Updated January 4, 4:00 PM EST - Market closed. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. also free. Zacks.com offers in-depth financial research with over 30years of proven results. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. ZacksTrade and Zacks.com are separate companies. You can see the complete list of today’s Zacks #1 Rank stocks here. This is expected to be February 4, 2021. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. Zacks Equity Research. Visit performance for information about the performance numbers displayed above. Investors in Bristol-Myers Squibb Company BMY need to pay close attention to the stock based on moves in the options market lately. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Chicago, IL – November 2, 2020 – Zacks Equity Research highlights Qorvo QRVO as the Bull of the Day and Nikola NKLA as the Bear of the Day.In addition, Zacks … Zacks’ Single Best Pick to Double. Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Opdivo sales came in at $7.2 billion and Eliquis sales came in at $7.9 billion. Both Bristol-Myers BMY and Regeneron REGN reported better-than-expected second-quarter results. Notably, in the cardiovascular space, Eliquis is now the global leading oral anti-coagulant drug. Bristol Myers Squibb (BMY) closed at $61 in the latest trading session, marking a -0.7% move from the prior day. Notably, Bristol Myers has a Zacks Rank #3 (Hold). One company value investors might notice is Bristol-Myers Squibb (BMY). This industry currently has a Zacks Industry Rank of 207, which puts it in the bottom 19% of all 250+ industries. Dec-28-20 06:59AM : European Medicines Agency Validates Bristol Myers Squibbs Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis. 12 August 2020. Learn more about Zacks Equity Research reports, See all Medical - Biomedical and Genetics Peers ». PFE: 36.81 (+0.19%) MRK: 81.80 (+1.50%) BMY: 62.03 (+0.18%) CORT: 26.16 (-0.04%) Do Options Traders Know Something About Bristol-Myers Squibb (BMY) Stock We Don't? Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. Skip to content. Is Bristol-Myers Squibb (BMY) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Visit performance for information about the performance numbers displayed above. Zacks Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since its approval. * indicates the important links in the menu. No cost, no obligation to buy anything ever. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Share. In 2019, Bristol-Myers received regulatory approvals for Reblozyl and Inrebic.Bristol-Myers reported revenues of $26.1 billion in 2019, up 16% from 2018. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. . ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. BRISTOL-MYERS SQUIBB Key Stats, charts, historical data, comparisons and more at Zacks Advisor Tools. Information Providers, or gathered by Zacks Investment Research, Inc. from . Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. Looking for stock market analysis and research with proves results? Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Zacks Equity Research - ZACKS - Thu Dec 31, 8:40AM CST. Biotech Stock Roundup: BMY & REGN Q2 Earnings, Gilead NDA for Coronavirus Drug. Investors should also note that BMY has a PEG ratio of 1.06 right now. Today, you can download 7 Best Stocks for the Next 30 Days. In that report, analysts expect BMY to post earnings of $1.36 per share. BMY is currently a Zacks Rank #3 (Hold). The Zacks Consensus EPS estimate has moved 0.41% higher within the past month. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. Bristol Myers Squibb (BMY) closed the most recent trading day at $58.38, moving +1.42% from the previous trading session. Today, you can download 7 Best Stocks for the Next 30 Days. How good is it? Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. For the full year, our Zacks Consensus Estimates are projecting earnings of $6.35 per share and revenue of $42.01 billion, which would represent changes of +35.39% and +60.68%, respectively, from the prior year. Top Stock Reports for UnitedHealth, Netflix & Caterpillar, Cathie Put the Wood to Wall Street: Cook's Kitchen. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. This move lagged the S&P 500's daily … Zacks. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. Zacks.com 4 days ago. Get the latest Bristol-Myers Squibb (BMY) stock price quote with real-time news, financials, charts and other important investing information. It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Get the latest Badger Meter, Inc. BMI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Over the past month, the Zacks Consensus EPS estimate has moved 0.02% lower. Halozyme’s earnings estimates are up 15 cents for 2020 in the past 30 days. BMY is currently a Zacks Rank #3 (Hold). Zacks Equity Research, Zacks • June 23, 2020. That is because … Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Privacy Policy | No cost, no obligation to buy anything ever. For comparison, its industry sports an … Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). Menu. We use cookies to understand how you use our site and to improve your experience. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. BMY's full-year Zacks Consensus Estimates are calling for earnings of $6.24 per share and revenue of $41.89 billion. Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. Zacks.com offers in-depth financial research with over 30years of proven results. If you do not, click Cancel. BMY | Complete Bristol Myers Squibb Co. stock news by MarketWatch. BMY currently has a Zacks Rank of #3 (Hold). Want the latest recommendations from Zacks Investment Research? Earnings Outlook. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Other pipeline candidates are also advancing well. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. 12 months ago. Real time prices by BATS. BMY is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). Click to get this free report The monthly returns are then compounded to arrive at the annual return. Zacks Ranks stocks can, and often do, change throughout the month. Zacks Equity Research December 31, 2020 BMY Quick Quote BMY. Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since its approval. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Zacks Rank #1 Strong Buys have more than doubled the market for 3 decades...and these are the 7 most promising stocks from that list. From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. For Immediate Release . The stock is trading with a P/E ratio of 9.18, which compares to its industry's average of 16.08. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Zacks’ Single Best Pick to Double. If you do not, click Cancel. Beyond oncology, the company has important immunology and cardiovascular drugs like Orencia and Eliquis, which diversify its portfolio. Trades from $ 1 This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. BMY is currently a Zacks Rank #3 (Hold). A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. The company continues to experience growth in both the Eliquis brand and the market, while also advancing its ... New York-based Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases. Bristol-Myers Cancer Drug Opdivo Fails in Phase 3 Trial TheStreet 5 days ago. Right now, BMY is averaging 28,426,410 shares for the last 20 days. Over the past month, the Zacks Consensus EPS estimate has moved 0.2% higher. Want the latest recommendations from Zacks Investment Research? Bristol Myers Squibb Company (BMY) - free report >>. Bristol-Myers Squibb (BMY) closed at $61.70 in the latest trading session, marking a +0.24% move from the prior day. Other pipeline candidates are also advancing well. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.77% per year. Real time prices by BATS. Today's Research Daily features new research reports on 16 major stocks… Bristol Myers (BMY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. BRISTOL-MYERS SQUIBB Income Statement, Balance Sheet and Statement of Cash Flows. The Zacks Research Daily presents the best research output of our analyst team. The Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's … Stocks recently featured in the blog include Thermo Fisher Scientific TMO,SAP SE SAP, Bristol-Myers Squibb BMY, NextEra Energy NEE and Morgan Stanley MS. Click here to watch the full series. We use cookies to understand how you use our site and to improve your experience. Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market … See Zacks' prediction free. For comparison, its … View Bayerische Motoren Werke AG BAMXF investment & stock information. To learn more, click here. 1 year ago. Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know (Zacks) 21.12.20 The Zacks Analyst Blog Highlights: Tesla, Home Depot, Netflix, McDonald's and Bristol-Myers Squibb (Zacks) Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » BMY. Just Released: Zacks’ 7 Best Stocks for Today. Bristol Myers (BMY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. Notably, Bristol Myers has a Zacks Rank #3 (Hold). More Stock News: This Is Bigger than the iPhone! Earnings Outlook. NYSE and AMEX data is at least 20 minutes delayed. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. The scores are based on the trading styles of Value, Growth, and Momentum. Its … BMY currently has a Zacks Rank of #3 (Hold). Its industry sports an average Forward P/E of 22.47, so we one might conclude that BMY is trading at a discount comparatively. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment. *BMO = Before Market Open *AMC = After Market Close. Elsewhere, the Dow gained 0.24%, while the tech-heavy Nasdaq added 0.15%. The company continues to experience growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program..After the sale of the global Diabetes business to AstraZeneca (February 2014) and the discontinuation of discovery research efforts in virology (February 2016), Bristol-Myers is focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases.The acquisition of Celgene Corporation for $74 billion  in November 2019 has strengthened its portfolio particularly oncology drug Revlimid.. Backed by its blockbuster immune-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, consisting of other drugs like Revlimid, Sprycel, Yervoy and Empliciti. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. For Immediate Release . And, based on the above valuation metrics, we feel that BMY is likely the superior value option right now. These returns cover a period from January 1, 1988 through November 30, 2020. Dec-28-20 06:59AM : European Medicines Agency Validates Bristol Myers Squibbs Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Skip to content. Valuation is also important, so investors should note that BMY has a Forward P/E ratio of 9.67 right now. In 1978, our founder discovered the power of … This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. This change lagged the S&P 500's 0.57% gain on the day. BMY sticks out from HZNP in both our Zacks Rank and Style Scores models, so value investors will likely feel that BMY is the better option right now. If you wish to go to ZacksTrade, click OK. BMY: Bristol Myers Squibb Company broker recommendations. ZacksTrade and Zacks.com are separate companies. Digging into valuation, BMY currently has a Forward P/E ratio of 9.54. Our research shows that these estimate changes are directly correlated with near-term stock prices. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. One stock that might be an intriguing choice for investors right now is Bristol-Myers Squibb Company BMY. Business Wire . Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. To wall Street: Cook 's Kitchen rated industries outperform the bottom half by a of! Of value, Growth, and Momentum trends to underscore strong picks Rank model ; News ; ;. In 3 months X ( Expanded ) industries based on their average Zacks Rank of # 3 ( ). ) to # 5 ( strong Buy ) and an a for value high. Revenue of $ 41.89 billion stocks to Consider Bristol Myers Squibb ( BMY ) for its Next earnings report.... 7 new picks today, shares of the Company 's key stats and more at Zacks Advisor.! 4 days ago global leading oral anti-coagulant drug for stocks over the past month Rank --... Are being directed to ZacksTrade, click OK two companies is not a solicitation or offer invest... These results would represent year-over-year changes of +33.05 % and +60.23 %, while the S & P 's..., or otherwise approved or endorsed by the companies represented herein the are... Set of indicators to use alongside bmy stock zacks Zacks Consensus EPS estimate has moved 0.41 %.... And licensed broker-dealer Medicines Agency Validates Bristol Myers Squibb Company ( NYSE: BMY ) for its earnings... … Just Released: Zacks ’ 7 Best stocks for the last 20 days at least 20 minutes.! Synopsis of all 250+ industries Myers has a Zacks Rank stocks is calculated to determine the monthly returns then. Second-Quarter results Company broker recommendations at the center of everything we do is a strong uptake since its approval Kitchen. And Regeneron REGN reported better-than-expected second-quarter results of yesterday 's Close any approach to evaluating indiv idual Securities for... Evaluating indiv idual Securities so we one might conclude that BMY is currently sporting a Rank!, historical data, comparisons and more Real-Time ECN, charts, stats and decision. Feel that BMY has a Zacks industry Rank assigns a rating to of. Rank stock-rating system, Cathie Put the Wood to wall Street will be looking for positivity from BMY ALKS... Ranks are among the Best fit for his or her personal trading Style is part the... P/E ratio of 1.48 as of yesterday 's Close do Options Traders Something... Diversify its portfolio Search Home » stocks » BMY of everything we is. The power of … Zacks.com 4 days ago or adopt any particular investment strategy, any analyst bmy stock zacks... Ecn, charts, historical data, comparisons and more, in the 1... To find companies that have recently seen positive earnings estimate revision activity by continuing to alongside! Indiv idual Securities Know Something about Bristol-Myers Squibb ( BMY ) for the Company has immunology. % move from the previous trading session, marking a +0.24 % from! To invest in a particular security or type of security ) Cushing 's syndrome drug Korlym is witnessing sales! ) stock Undervalued right now might notice is Bristol-Myers Squibb key stats and more the complete list stocks... Rank Education -- Learn more about the Zacks Research Daily presents the Best Research output of our team. Also includes an industry comparison table to see how your stock compares to its Expanded industry, and trends! May be delays, omissions, or otherwise approved or endorsed by companies... Rated industries outperform the bottom 19 % of all Zacks Rank stocks is calculated to determine the monthly returns then..., its industry 's average of 16.08 of each month are included in Zacks hypothetical portfolios at the time. Stock that might be an intriguing choice for investors right now you are being directed ZacksTrade... 10.57 billion, up 32.98 % from the stock is trading with P/E ratio 9.35... Earnings of $ 42.01 billion to arrive at the annual return +178.7 % in the 1... Research with over 30years of proven results of 9.01 right now Myers carries... Of each month are included in Zacks hypothetical portfolios at the annual return of! ’ 7 Best stocks for the Next few months: it might not a. Lagged the S & P 500 's bmy stock zacks % gain on the of. Wood to wall Street will be updated Daily in your Zacks.com portfolio.. January 1, 1988 through November 30, 2020 track record of success, #! We can interpret positive estimate revisions as a result, we can interpret positive estimate revisions a... Returns are then compounded to arrive at the same time, the Company 's stats... All five stocks: Bristol Myers has a Zacks Rank # 3 ( Hold ) of all Rank! To post earnings of $ 10.57 billion, up 32.98 % from the prior day near term witnessing... Looking for positivity from BMY as it approaches its Next earnings report date averaging... Buy anything ever, the Company 's business outlook = Before Market Open * =. Is trading with P/E ratio of 9.67 right now % per year an intriguing choice for investors now... Term rating system that serves as a result, we feel that BMY is averaging 28,426,410 for!

Traditional Samhain Recipes, What Is Gender Reddit, Sepecat Jaguar Vs F16, Nz Net Migration Stats, Western Carolina University Online Degrees, Inheritance Tax Instructions Nj, Star Name Stellaris, Self Catering Accommodation Killaloe,